# ENZEEVU
> **BLA761382** · Biologics License Application · Sponsor: SANDOZ INC · Approved 2024-08-09
## Drug
- **FDA Application Number:** BLA761382
- **Application type:** Biologics License Application
- **Brand name:** ENZEEVU
- **Generic name:** Aflibercept-Abzv
- **Active ingredients:** AFLIBERCEPT-ABZV
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** SANDOZ INC
- **First approval:** 2024-08-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761382)
---
*MORVS · CC0 1.0*